This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Yeda Research and Develpment & Co. Ltd. Active years: 2010-2013.
Company Filing History:
Years Active: 2010-2013
Title: Rachel Eren: Innovator in Hepatitis B Antibody Formulations
Introduction
Rachel Eren is a prominent inventor based in Moshav Netaim, Israel. She has made significant contributions to the field of biotechnology, particularly in the development of antibody formulations for the treatment of hepatitis B virus (HBV) infections. With a total of 2 patents, her work is paving the way for advancements in medical treatments.
Latest Patents
Eren's latest patents focus on stabilized anti-hepatitis B (HBV) antibody formulations. These inventions provide liquid formulations of antibodies or fragments that specifically bind to HBV antigens. The formulations exhibit remarkable stability, with low to undetectable levels of aggregation, ensuring minimal loss of biological activity even during prolonged storage. Furthermore, her inventions offer methods for preventing, treating, or ameliorating symptoms associated with HBV infection, showcasing her commitment to improving patient outcomes.
Career Highlights
Rachel Eren is associated with Yeda Research and Development Co. Ltd., where she continues to innovate in the field of biotechnology. Her work has garnered attention for its potential impact on public health, particularly in combating viral infections.
Collaborations
Eren collaborates with notable colleagues, including Shlomo Dagan and Hemant Kumar Misra. These partnerships enhance her research efforts and contribute to the development of effective therapeutic solutions.
Conclusion
Rachel Eren's contributions to the field of biotechnology, particularly in the development of stabilized anti-HBV antibody formulations, highlight her role as an influential inventor. Her work not only advances scientific knowledge but also holds promise for improving treatment options for those affected by hepatitis B.